Robert A. Cascella is an American businessperson who has been at the head of 7 different companies and occupies the position of Chairman of Neuronetics, Inc., Chief Executive Officer at Philips Medical Systems MR, Inc. and President & Chief Executive Officer at Invivo Corp. Mr. Cascella is also on the board of Celestica, Inc., Metabolon, Inc. and Mirion Technologies, Inc.
Robert A. Cascella previously occupied the position of Chairman at DySIS Medical Ltd., Chairman for Miranda Medical Centre, President, Chief Executive Officer & Director at Hologic, Inc., President, Chief Operating & Financial Officer at Fischer Imaging Corp., Chief Business Leader-Diagnosis & Treatment, EVP at Koninklijke Philips NV, Managing Partner at CFG Capital LLC, Director-Accounting & Financial Planning at PerkinElmer, Inc. (United States), Chief Operating Officer & VP-Finance at NeoVision Corp. and Principal at American Cancer Society, Inc.
He received an undergraduate degree from Fairfield University.
What is Robert A. Cascella's net worth?
The estimated net worth of Robert A. Cascella is at least $155,542.50 as of August 16th, 2023. Mr. Cascella owns 41,478 shares of Neuronetics stock worth more than $155,543 as of April 25th. This net worth estimate does not reflect any other investments that Mr. Cascella may own. Learn More about Robert A. Cascella's net worth.
How do I contact Robert A. Cascella?
Has Robert A. Cascella been buying or selling shares of Neuronetics?
Robert A. Cascella has not been actively trading shares of Neuronetics during the last quarter. Most recently, on Monday, November 22nd, Robert Cascella bought 15,000 shares of Neuronetics stock. The stock was acquired at an average cost of $4.10 per share, with a total value of $61,500.00. Learn More on Robert A. Cascella's trading history.
Who are Neuronetics' active insiders?
Are insiders buying or selling shares of Neuronetics?
In the last twelve months, insiders at the sold shares 17 times. They sold a total of 202,262 shares worth more than $610,676.94. The most recent insider tranaction occured on February, 28th when EVP William Andrew Macan sold 22,377 shares worth more than $70,711.32. Insiders at Neuronetics own 9.8% of the company.
Learn More about insider trades at Neuronetics. Information on this page was last updated on 2/28/2024.
